Kissei Pharmaceutical Co., Ltd. (KSPHF)
OTCMKTS · Delayed Price · Currency is USD
30.28
+3.15 (11.61%)
At close: Aug 6, 2025
Kissei Pharmaceutical Market Cap
Kissei Pharmaceutical has a market cap or net worth of $1.21 billion as of August 22, 2025. Its market cap has increased by 27.79% in one year.
Market Cap
1.21B
Enterprise Value
898.26M
Revenue
619.35M
Ranking
n/a
PE Ratio
14.12
Stock Price
$30.28
Market Cap Chart
Since March 25, 1992, Kissei Pharmaceutical's market cap has increased from 907.85M to 1.21B, an increase of 33.39%. That is a compound annual growth rate of 0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.22B | 7.96% |
| Dec 30, 2024 | 1.13B | 15.79% |
| Dec 29, 2023 | 978.45M | 8.45% |
| Dec 30, 2022 | 902.22M | -0.06% |
| Dec 30, 2021 | 902.76M | -10.76% |
| Dec 30, 2020 | 1.01B | -24.45% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |